{"disease":{"id":"pellagra","name":"Pellagra","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"inositol","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inosital","generic_name":"INOSITOL","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"inositol","quality_score":null,"revenue":null,"mechanism":"Inosital works by influencing the metabolism of lipids in the body."},{"drug_id":"nicotinamide","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Nicotinamide","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"NAD-dependent protein deacetylase sirtuin-2","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"inositol-nicotinate","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hexanicit","generic_name":"inositol nicotinate","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"inositol nicotinate","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"myoinositol","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Myoinositol","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"nicotinyl-alcohol","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyridylcarbinol","generic_name":"nicotinyl alcohol","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"nicotinyl alcohol","quality_score":null,"revenue":null,"mechanism":"Pyridylcarbinol works by providing the body with a precursor to NAD+, a crucial coenzyme involved in energy metabolism."},{"drug_id":"nicotine","indication_name":"Pellagra","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nicorette","generic_name":"NICOTINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"Cholinergic Nicotinic Agonist [EPC]","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}